This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. The award, with a ceiling value of $4,295.76, is a firm-fixed-price contract with an ultimate completion date of August 1, 2024. AmerisourceBergen, through its Corporate Office division, is responsible for providing these prescription eye medications to support the healthcare needs of military treatment facilities and other federal beneficiaries. This contract is not designated as a set-aside. Additionally, AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for delivering a comprehensive range of medical commodities and pharmaceutical products to federal agencies and healthcare programs.
Generated 10/30/24, 9:46 AM